US EditionHarbour BioMed Appoints Youchen Chen as Chief Financial Officer
- Harbour BioMed, a biopharmaceutical firm, named Youchen Chen as CFO in 2023.
- Chen had increasing responsibilities since joining, including finance and investor relations.
- Based in Shanghai and Hong Kong, Chen will report to Jingsong Wang.
- Founder Jingsong Wang stated YC brought a strategic mindset and financial skills.
- Chen will use his expertise to improve shareholder value and guide strategic growth.
Insights by Ground AI
Does this summary seem wrong?
37 Articles
37 Articles
All
Left
2
Center
14
Right
1
The Berkshire Eagle+35 Reposted by 35 other sources
Harbour BioMed Appoints Youchen Chen as Chief Financial Officer
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , April 9, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics focusing on immunology and oncology, today announced the appointment of…
Coverage Details
Total News Sources37
Leaning Left2Leaning Right1Center14Last UpdatedBias Distribution82% Center
Bias Distribution
- 82% of the sources are Center
82% Center
12%
C 82%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
